The Patent Finder

Tularik Inc.

0 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
none
Next term end

When these terms end

Held patents by the year their term ends
2026 · 0 end2027 · 02028 · 02029 · 02030 · 0

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

No patent on this record is in force and held under this name now.

Also on record: 125 lapsed for an unpaid fee · 68 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

20 abandoned · 1 no status recorded

Showing 1 to 10 of 21, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
11/332,054CXCR3 antagonistsJan 13, 2006Abandoned
11/086,846Murine G Protein-Coupled ReceptorsMar 21, 2005Abandoned
11/038,360Novel receptorsJan 18, 2005Abandoned
10/916,868Arylsulfonamidobenzylic compoundsAug 11, 2004Abandoned
10/867,183Gene amplification and overexpression in cancerJun 15, 2004Abandoned
10/817,418Gene amplification and overexpression in cancerApr 5, 2004Abandoned
10/749,530Dec 30, 2003No status recorded
10/456,932Combination therapeutic compositions and method of useJun 5, 2003Abandoned
10/278,851Quinolinyl and Benzothiazolyl ModulatorsOct 21, 2002Abandoned
10/273,575Polypeptides and nucleic acids associated with cancerOct 18, 2002Abandoned
10 of 21 applications shown.
Pro members see all 21 published applications.
Pro members: see all 21 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited